# Aldeyra Therapeutics, Inc.: Form 8-K, filed Jun 11, 2025

- Company: [Aldeyra Therapeutics, Inc.](/companies/aldx.md) (CIK 1341235)
- Form: 8-K
- Filed: 2025-06-11
- Accepted by EDGAR: Jun 11, 2025, 16:01 ET
- Period: 2025-06-10
- Accession: 0000950170-25-084820
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1341235/000095017025084820/aldx-20250610.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1341235/000095017025084820/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1341235/000095017025084820/aldx-20250610.htm

Filed Jun 11, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-084820. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.